Companies: 10,795·Total market cap: $144.5T
Bristol-Myers Squibb Company Ce

Bristol-Myers Squibb Company Ce

CELG-RINYSEHealthcare● Active
$0.10
+$0.00(+0.10%)
Market Cap$203798586
P/E Ratio—
52W High$0.1229
52W Low$0.0997
Overview
股票排行：Drug Manufacturers - General·Healthcare·查看全部市值排行 →

Bristol-Myers Squibb Company Ce（CELG-RI）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CELG-RI · 截至 Jun 8, 2026

关键指标

EPS (TTM)$8.32celg-ri eps ttm · celg-ri earnings per shareEarnings history
PE Ratio (TTM)0.0×celg-ri pe ratio ttm · celg-ri price to earningsPE Ratio deep dive
Revenue (TTM)$17.0Bcelg-ri revenue ttm · celg-ri annual revenueFull revenue history
Dividend Yield36.18%does celg-ri pay dividends · celg-ri dividend yieldDividend history
Shares Outstanding733.8Mcelg-ri shares outstanding · celg-ri floatShares outstanding history
Next EarningsJul 30, 2026Est.celg-ri earnings date · celg-ri next earningsEarnings history

探索 Bristol-Myers Squibb Company Ce 数据

celg-ri stock data · financials
市值$203.8Mcelg-ri market cap · celg-ri valuation
分析师预测—
股息36.18%does bristol-myers squibb company ce pay dividends · celg-ri dividend yield
营收$15.3B+17.52%bristol-myers squibb company ce annual revenue · celg-ri revenue
盈利EPS $5.51+46.15%celg-ri earnings · celg-ri eps
市盈率0.0×celg-ri pe ratio · celg-ri price to earnings

财务快照

完整财报
FY 2018Revenue$15.28B▲ +17.52% YoY
201620172018
bristol-myers squibb company ce revenue · celg-ri revenue 2018
FY 2018Net Income$4.05B▲ +37.62% YoY
201620172018
bristol-myers squibb company ce net income · celg-ri profit 2018
FY 2018EPS$5.51▲ +46.15% YoY
201620172018
celg-ri eps · bristol-myers squibb company ce earnings per share 2018
TTM:Revenue: $16.98BNet Income: $5.88BEPS: $8.32View income statement →

股票表现

完整历史
1D-16.85%
1W-28.73%
1M-22.95%
3M-16.85%
YTD+38.66%
1Y+287.94%
5Y-35.64%

关于 Bristol-Myers Squibb Company Ce

CEOChristopher S. Boerner
IPO DateNov 21, 2019
Employees34,100
CountryUS
Websitebms.com

Bristol-Myers Squibb Company Ce Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced fr…

Drug Manufacturers - GeneralHealthcareNYSEUS

what is bristol-myers squibb company ce · celg-ri stock overview · bristol-myers squibb company ce company profile · who is bristol-myers squibb company ce ceo · celg-ri NYSE · bristol-myers squibb company ce headquarters · bristol-myers squibb company ce business segments

关于股票概览与关键数据

Bristol-Myers Squibb Company Ce（CELG-RI）是 Drug Manufacturers - General 行业的 Healthcare 类公司，于 Nov 21, 2019 在 NYSE 上市。截至最近交易日，CELG-RI 股价为 $0.10，市值约为 $203.8M。过去12个月累计回报 +287.94%，年初至今回报 +38.66%。

2018 财年 Bristol-Myers Squibb Company Ce 营收 $15.3B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Bristol-Myers Squibb Company Ce（CELG-RI）股价为 $0.10，在 NYSE 上市，52周区间为 $0.10 – $0.12。

CELG-RI 最新股价CELG-RI quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议